Updated Date: Tue, 03 Dec 2024 00:00:00 EST
Successful phase 1 study highlights potential of roginolisib
Promising results set stage for European marketing authorization
Updated Date: Tue, 03 Dec 2024 00:00:00 EST
Updated Date: Tue, 03 Dec 2024 00:00:00 EST
Updated Date: Tue, 03 Dec 2024 00:00:00 EST
Updated Date: Tue, 03 Dec 2024 00:00:00 EST
Despite decades of advances in prevention, diagnosis, and treatment worldwide, sexually transmitted infections (STIs) remain a major public […]
Radiation is one of the most effective ways to kill a tumor. But these therapies are indiscriminate, and […]
New cell therapy shows potential in treating advanced blood disorder